Is there a Lokelma shortage in 2026? Get the latest update on Lokelma availability, why it's hard to find, current pricing, and what you can do as a patient.
If you're a patient who depends on Lokelma (Sodium Zirconium Cyclosilicate) to manage your potassium levels, hearing rumors about a shortage is alarming. High potassium is a serious condition — you can't just skip doses and hope for the best.
So let's cut through the noise and give you a clear, honest picture of what's happening with Lokelma availability in 2026.
As of early 2026, Lokelma is not listed on the FDA Drug Shortage Database or the ASHP (American Society of Health-System Pharmacists) Drug Shortages List. This means there is no officially recognized nationwide shortage of Lokelma.
However — and this is an important "however" — many patients still report difficulty finding Lokelma at their local pharmacies. The disconnect between "no official shortage" and "I can't find it anywhere" is real and frustrating.
The reality is that Lokelma availability issues are usually localized stocking problems, not a manufacturing or supply chain crisis. Because Lokelma is a specialty medication that not every pharmacy carries, patients in certain areas can face genuine difficulty getting their prescriptions filled — even when the drug is technically available through distributors.
Several factors contribute to the difficulty patients experience when trying to fill their Lokelma prescriptions:
Lokelma is made exclusively by AstraZeneca. There's no generic version available, and no other company produces it. When a drug has only one manufacturer, there's no backup supply if there's a production delay, shipping disruption, or unexpected increase in demand.
Lokelma is classified as a specialty medication. This means most retail pharmacies — the CVS, Walgreens, or Rite Aid you pass every day — don't routinely stock it. They might carry common blood pressure medications or diabetes drugs in large quantities, but a potassium binder for hyperkalemia? That often requires a special order.
The number of patients being prescribed Lokelma has been growing. As more doctors recognize it as a safer, more effective alternative to older potassium binders like Kayexalate, demand has increased. This growing demand puts pressure on the existing single-source supply chain.
Insurance barriers like prior authorization and step therapy requirements can delay patients from getting Lokelma. While these aren't shortage issues per se, they add to the overall difficulty of accessing the medication and can create periods where patients go without treatment.
Cost remains a significant barrier to Lokelma access for many patients:
For a complete breakdown of savings strategies, read our guide on how to save money on Lokelma in 2026.
While no generic version of Lokelma is expected in the near term, patients in 2026 have more resources than ever to manage both availability and cost:
If you need Lokelma today, here's your action plan:
For more detailed strategies, check out our full guide on how to find Lokelma in stock near you.
If Lokelma truly isn't available in your area — even through specialty pharmacies and mail order — talk to your doctor about temporary alternatives. Veltassa (Patiromer) is the most similar medication, while Kayexalate (Sodium Polystyrene Sulfonate) is a more widely available (though older) option. Read our full comparison of alternatives to Lokelma.
Do not stop managing your potassium levels. Uncontrolled hyperkalemia can lead to dangerous heart rhythm problems. If you can't access Lokelma, work with your doctor to find a bridge treatment while you sort out availability.
There's no official Lokelma shortage in 2026, but the day-to-day experience of finding it can still be challenging. The combination of single-manufacturer supply, specialty drug status, and insurance complexity means patients need to be proactive about securing their medication.
Use the tools and strategies available to you — Medfinder, AstraZeneca's support programs, specialty pharmacies, and your healthcare team. Hyperkalemia management is too important to leave to chance.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
